X4 Pharmaceuticals (XFOR) Shares Outstanding (Diluted Average) (2020 - 2025)

X4 Pharmaceuticals has reported Shares Outstanding (Diluted Average) for 6 years, with the latest figure at $42.3 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) rose 531.04% year-over-year to $42.3 million; the trailing twelve-month figure through Dec 2025 stood at $42.3 million (up 531.04% YoY), and the FY2025 full-year result was $42.3 million, up 531.04% from the prior year.
• Shares Outstanding (Diluted Average) for Q4 2025 stood at $42.3 million, down from $43.3 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $197.0 million in Q3 2023, with the low at $5.9 million in Q4 2023.
• Historically, Shares Outstanding (Diluted Average) has averaged $50.7 million across 5 years, with a median of $30.2 million in 2021.
• Annual changes were most pronounced in 2024 — Shares Outstanding (Diluted Average) tumbled 96.61% — and 2025, when it jumped 547.11%.
• X4 Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $25.7 million in 2021, then surged by 146.71% to $63.5 million in 2022, then tumbled by 90.67% to $5.9 million in 2023, then grew by 13.08% to $6.7 million in 2024, then surged by 531.04% to $42.3 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $42.3 million (Q4 2025), $43.3 million (Q3 2025), and $7.1 million (Q2 2025), per Business Quant data.